Education
About Us
Working with TipRanks
Follow Us
NextCure Inc (NXTC)
NASDAQ:NXTC
Total Valuation
NextCure has a market cap or net worth of $8.15M. The enterprise value is -$31.31M.
Market Cap$8.15M
Enterprise Value-$31.31M
Share Statistics
NextCure has 28.01M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28.01M
Owened by Insiders
Owened by Instutions37.93%
Financial Efficiency
NextCure’s return on equity (ROE) is -0.85 and return on invested capital (ROIC) is -83.81%.
Return on Equity (ROE)-85.00%
Return on Assets (ROA)-68.83%
Return on Invested Capital (ROIC)-83.81%
Return on Capital Employed (ROCE)-83.81%
Revenue Per Employee$0
Profits Per Employee-$1,294,279.07
Employee Count43
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NextCure is -0.39. NextCure’s PEG ratio is 0.03.
PE Ratio-0.39
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.33
Price to FCF-0.52
Price to Operating Cash Flow-0.53
PEG Ratio0.03
Income Statement
In the last 12 months, NextCure had revenue of $0.00 and earned -$55.65M in profits. Earnings per share was -$1.98.
Revenue$0.00
Gross Profit-$1.64M
Operating Income-$57.21M
Pretax Income-$55.65M
Net Income-$55.65M
EBITDA-54.34M
Earnings Per Share (EPS)-1.98
Cash Flow
In the last 12 months, operating cash flow was -$40.80M and capital expenditures -$474.00K, giving a free cash flow of -$41.28M billion.
Operating Cash Flow-$40.80M
Free Cash Flow-$41.28M
Free Cash Flow per Share-$1.47
Dividends & Yields
NextCure pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-191.45%
Earnings Yield-258.13%
Stock Price Statistics
Beta0.94
52-Week Price Change-82.63%
50-Day Moving Average0.64
200-Day Moving Average1.14
Relative Strength Index (RSI)24.43
Average Volume (3m)153.28K
Important Dates
NextCure upcoming earnings date is May 1, 2025, After Close.
Last Earnings DateMar 6, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend Date―
Financial Position
NextCure as a current ratio of 7.50, with Debt / Equity ratio of 0.08
Current Ratio7.50
Quick Ratio7.50
Debt to Market Cap0.24
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NextCure has paid $896.72K in taxes.
Income Tax$896.72K
Effective Tax Rate0.00%
Enterprise Valuation
NextCure EV to EBITDA ratio is 0.02, with an EV/FCF ratio of 0.02.
EV to Sales0.00
EV to EBITDA0.02
EV to Free Cash Flow0.02
EV to Operating Cash Flow0.02
Balance Sheet
NextCure has $68.62M in cash and marketable securities with $5.95M in debt, giving a net cash position of -$62.67M billion.
Cash & Marketable Securities$68.62M
Total Debt$5.95M
Net Cash-$62.67M
Net Cash Per Share-$2.24
Tangible Book Value Per Share$2.34
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NextCure is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.00
Price Target Upside934.48%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast11.66%